Blog
About

30
views
0
recommends
+1 Recommend
0 collections
    4
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen.

      The Journal of Biological Chemistry

      Zebrafish Proteins, Acetylation, Xenopus, Wnt Proteins, pharmacology, Valproic Acid, Transfection, Transcription, Genetic, Time Factors, Teratogens, Signal Transduction, metabolism, Recombinant Fusion Proteins, Proto-Oncogene Proteins, Promoter Regions, Genetic, Plasmids, Luminescent Proteins, Lithium, Inhibitory Concentration 50, Hydroxamic Acids, Humans, Histones, Histone Deacetylases, Histone Deacetylase Inhibitors, Histone Deacetylase 1, Green Fluorescent Proteins, Glycogen Synthase Kinase 3, Dose-Response Relationship, Drug, Cell Line, Calcium-Calmodulin-Dependent Protein Kinases, Antimanic Agents, Anticonvulsants, Animals

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Valproic acid is widely used to treat epilepsy and bipolar disorder and is also a potent teratogen, but its mechanisms of action in any of these settings are unknown. We report that valproic acid activates Wntdependent gene expression, similar to lithium, the mainstay of therapy for bipolar disorder. Valproic acid, however, acts through a distinct pathway that involves direct inhibition of histone deacetylase (IC(50) for HDAC1 = 0.4 mm). At therapeutic levels, valproic acid mimics the histone deacetylase inhibitor trichostatin A, causing hyperacetylation of histones in cultured cells. Valproic acid, like trichostatin A, also activates transcription from diverse exogenous and endogenous promoters. Furthermore, valproic acid and trichostatin A have remarkably similar teratogenic effects in vertebrate embryos, while non-teratogenic analogues of valproic acid do not inhibit histone deacetylase and do not activate transcription. Based on these observations, we propose that inhibition of histone deacetylase provides a mechanism for valproic acid-induced birth defects and could also explain the efficacy of valproic acid in the treatment of bipolar disorder.

          Related collections

          Author and article information

          Journal
          11473107
          10.1074/jbc.M101287200

          Comments

          Comment on this article